The adventure in biotech continues….
What’s next… When we left off before my judgement seemed to have paid off at great speed! But this just left me with a dilemma, should I cut and run or stay in? To try and get some perspective I had a look at Arix’ portfolio in detail and took a couple of mainstream Biotech